Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-05-10T03:01:27.116Z Has data issue: false hasContentIssue false

1932 – Pharmacotherapy Of Borderline Personality Disorder During The Time

Published online by Cambridge University Press:  15 April 2020

A. Grambal
Affiliation:
Psychiatry, Olomouc, Czech Republic
Z. Grambalová
Affiliation:
Neurology, University Hospital Olomouc, Olomouc, Czech Republic
J.P. Praško
Affiliation:
Psychiatry, Olomouc, Czech Republic

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

In patients suffering from borderline personality disorder (BPD) primarily psychotherapeutic care is indicated. Pharmacotherapy is considered as adjuvant and often controversial way of treatment.

Objectives

Demonstration of pharmacological approach to BPD patients in Olomouc Czech Republic and compare with treatment guidelines. treatment guidelines.

Aims

The aim of our study was to compare treatment of BPD patients in 2007 and 2011

Method

The paper examines the state in 2007 and 2011 in BPD patients at the Department of Psychiatry, University Hospital. Our study included outpatients and inpatients treated in all departments. Inclusion criteria were diagnosis BPD. Medication was assessed according to the documentation at discharge or during outpatient care according to the transcript record.

Results

In most cases are BPD patients treated according to current guidelines. The treatment consists of SSRI antidepressants, anticonvulsants and second-generation of antipsychotics. Problem can be considered in some cases with medication dosage, combination, administration of benzodiazepine anxiolytics, hypnotics.

Conclusion

BPD patients are treated according to current recommendations. Inpatients are more medicated than outpatients. The reason is probably in relation with the severity of the symptoms. Medication did not differ from the majority of best practices. But with a lack of strong evidence about its effect, it seems appropriate to move towards its reduction. Supported by the project IGA MZ CR NT 11047-4/2010

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2013
Submit a response

Comments

No Comments have been published for this article.